CIK 0000914475 · Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330525145
- Phone
- (858) 617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-29 | Onyia Jude Chief Scientific Officer | Option exercise 10b5-1 | +4,426 | 17,780 | ||
| 2024-11-29 | Onyia Jude Chief Scientific Officer | Sale 10b5-1 | −2,331 | $126.29 | $294K | 15,449 |
| 2024-11-29 | Onyia Jude Chief Scientific Officer | Option exercise · Restricted Stock Unit 10b5-1 | −4,426 | 4,426 | ||
| 2024-11-08 | ROBERTS EIRY Chief Medical Officer | Option exercise | +5,140 | $77.81 | $400K | 28,856 |
| 2024-11-08 | ROBERTS EIRY Chief Medical Officer | Option exercise | +1,233 | $81.05 | $100K | 30,089 |
| 2024-11-08 | ROBERTS EIRY Chief Medical Officer | Option exercise | +971 | $102.90 | $100K | 31,060 |
| 2024-11-08 | ROBERTS EIRY Chief Medical Officer | Option exercise | +1 | $79.02 | $79 | 31,061 |
| 2024-11-08 | ROBERTS EIRY Chief Medical Officer | Option exercise · Incentive Stock Option | −5,140 | 0 | ||
| 2024-11-08 | ROBERTS EIRY Chief Medical Officer | Option exercise · Incentive Stock Option | −1,233 | 0 | ||
| 2024-11-08 | ROBERTS EIRY Chief Medical Officer | Option exercise · Incentive Stock Option | −971 | 0 | ||
| 2024-11-08 | ROBERTS EIRY Chief Medical Officer | Option exercise · Incentive Stock Option | −1 | 1,265 | ||
| 2024-11-04 | SHERWIN STEPHEN A Director | Gift | −2,000 | 24,504 | ||
| 2024-11-01 | Gano Kyle Chief Executive Officer | Grant or award · Restricted Stock Unit | +2,455 | 2,455 | ||
| 2024-11-01 | Gano Kyle Chief Executive Officer | Grant or award · Stock Option | +13,344 | 13,344 | ||
| 2024-10-03 | Boyer David W. Chief Corp. Affairs Officer | Sale 10b5-1 | −1,295 | $113.66 | $147K | 377 |
| 2024-09-13 | Boyer David W. Chief Corp. Affairs Officer | Sale 10b5-1 | −3,461 | $121.88 | $422K | 1,672 |
| 2024-08-15 | RASTETTER WILLIAM H Director | Sale | −14,250 | $146.69 | $2.1M | 37,491 |
| 2024-08-13 | LYONS GARY A Director | Option exercise 10b5-1 | +11,570 | $42.76 | $495K | 130,617 |
| 2024-08-13 | LYONS GARY A Director | Sale 10b5-1 | −11,570 | $150.43 | $1.7M | 119,047 |
| 2024-08-13 | LYONS GARY A Director | Option exercise · Non-Qualified Stock Option 10b5-1 | −11,570 | 0 |
Page 28 of 49 · 963 trades